CPC A61K 31/702 (2013.01) [A23L 33/12 (2016.08); A23L 33/125 (2016.08); A23L 33/135 (2016.08); A23L 33/155 (2016.08); A23L 33/16 (2016.08); A23L 33/175 (2016.08); A23L 33/18 (2016.08); A23L 33/22 (2016.08); A23L 33/24 (2016.08); A23L 33/40 (2016.08); A61K 31/202 (2013.01); A61K 31/59 (2013.01); A61K 31/715 (2013.01); A61K 31/717 (2013.01); A61K 31/718 (2013.01); A61K 31/733 (2013.01); A61K 31/736 (2013.01); A61K 33/06 (2013.01); A61K 35/745 (2013.01); A61K 35/747 (2013.01); A61P 7/08 (2018.01); A23V 2002/00 (2013.01)] | 14 Claims |
1. A method for:
treating and/or reducing methylmalonic acidemia (MMA) and/or propionic acidemia (PA);
dietary management of MMA and/or PA; and/or
reducing gut flora induced production of propionic acid,
in a human subject having an age of at least 3 years and suffering from MMA or PA, wherein the method comprises administering to the human subject a composition comprising a fiber mixture, wherein the fiber mixture comprises galactooligosaccharides and 1.5-25 wt % resistant starch based on a total weight of the fiber mixture.
|